| Primary |
| Urinary Tract Infection |
41.5% |
| Product Used For Unknown Indication |
38.1% |
| Cystitis |
8.4% |
| Multiple Sclerosis |
2.5% |
| Premedication |
1.7% |
| Prophylaxis Urinary Tract Infection |
1.4% |
| Infection Prophylaxis |
0.8% |
| Alopecia |
0.6% |
| Dysuria |
0.6% |
| Hypertension |
0.6% |
| Multiple Sclerosis Relapse |
0.6% |
| Psoriatic Arthropathy |
0.6% |
| Sinusitis |
0.6% |
| Uti |
0.6% |
| Antibiotic Therapy |
0.3% |
| Back Pain |
0.3% |
| Bipolar Disorder |
0.3% |
| Blood Pressure |
0.3% |
| Cerebrovascular Accident Prophylaxis |
0.3% |
| Colon Cancer Metastatic |
0.3% |
|
| Pyrexia |
16.5% |
| Nausea |
8.7% |
| Vomiting |
7.8% |
| Paraesthesia |
6.8% |
| Rash |
6.8% |
| Tremor |
5.8% |
| Dyspnoea |
4.9% |
| Syncope |
4.9% |
| Urticaria |
4.9% |
| Weight Decreased |
4.9% |
| Back Pain |
2.9% |
| Hepatic Failure |
2.9% |
| Lung Disorder |
2.9% |
| Pneumonitis |
2.9% |
| Pruritus |
2.9% |
| Pulmonary Fibrosis |
2.9% |
| Pulmonary Oedema |
2.9% |
| Toxicity To Various Agents |
2.9% |
| Urinary Tract Infection |
2.9% |
| Alopecia |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
52.7% |
| Hypertension |
11.3% |
| Urinary Tract Infection |
7.8% |
| Convulsion |
4.0% |
| Drug Use For Unknown Indication |
3.9% |
| Depression |
3.3% |
| Cystitis |
2.4% |
| Pain |
1.7% |
| Anaesthesia |
1.5% |
| Foetal Exposure During Pregnancy |
1.4% |
| Atrial Fibrillation |
1.3% |
| Blood Triglycerides Increased |
1.3% |
| Ingrowing Nail |
1.3% |
| Prophylaxis |
1.2% |
| Arthralgia |
1.0% |
| Rheumatoid Arthritis |
0.9% |
| Blood Pressure Abnormal |
0.8% |
| Crohn's Disease |
0.8% |
| Blood Pressure |
0.7% |
| Colitis Ulcerative |
0.7% |
|
| Drug Hypersensitivity |
22.9% |
| Urinary Tract Infection |
9.5% |
| Pulmonary Malformation |
7.6% |
| Vomiting |
7.6% |
| Premature Labour |
4.8% |
| Weight Decreased |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Body Temperature Increased |
3.8% |
| Headache |
3.8% |
| Loss Of Consciousness |
3.8% |
| Pruritus |
3.8% |
| Tremor |
3.8% |
| Abdominal Discomfort |
2.9% |
| Insomnia |
2.9% |
| Renal Disorder |
2.9% |
| Unresponsive To Stimuli |
2.9% |
| Abdominal Distension |
1.9% |
| Arterial Occlusive Disease |
1.9% |
| Arteriosclerosis Coronary Artery |
1.9% |
| Blood Count Abnormal |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.2% |
| Drug Use For Unknown Indication |
12.9% |
| Depression |
8.6% |
| Urinary Tract Infection |
8.5% |
| Pain |
8.3% |
| Multiple Sclerosis |
5.9% |
| Contraception |
4.8% |
| Crohn's Disease |
4.1% |
| Hypertension |
3.7% |
| Anxiety |
3.3% |
| Rheumatoid Arthritis |
3.2% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Osteoporosis |
2.6% |
| Multiple Myeloma |
1.9% |
| Migraine |
1.8% |
| Premenstrual Syndrome |
1.7% |
| Prophylaxis |
1.7% |
| Restless Legs Syndrome |
1.5% |
| Breast Cancer |
1.5% |
| Nausea |
1.4% |
|
| Urinary Tract Infection |
22.2% |
| Ventricular Septal Defect |
9.7% |
| Weight Decreased |
9.3% |
| Vomiting |
7.5% |
| Pulmonary Embolism |
6.4% |
| Pain |
6.0% |
| Weight Increased |
5.2% |
| Viral Infection |
4.4% |
| Thrombocytopenia |
2.9% |
| Vision Blurred |
2.9% |
| Nausea |
2.7% |
| Pyrexia |
2.7% |
| Tremor |
2.7% |
| Cholecystitis Chronic |
2.3% |
| Death |
2.3% |
| Cholelithiasis |
2.1% |
| Diarrhoea |
2.1% |
| Drug Exposure During Pregnancy |
2.1% |
| Drug Ineffective |
2.1% |
| Transient Ischaemic Attack |
2.1% |
|
| Interacting |
| Hypertension |
25.0% |
| Cystitis |
15.0% |
| Convulsion |
13.3% |
| Blood Pressure Abnormal |
8.3% |
| Ingrowing Nail |
8.3% |
| Flushing |
5.0% |
| Heart Rate Abnormal |
5.0% |
| Infection |
5.0% |
| Renal Disorder |
5.0% |
| Crohn's Disease |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Product Used For Unknown Indication |
3.3% |
|
| Urinary Tract Infection |
26.7% |
| Metrorrhagia |
13.3% |
| Dehydration |
6.7% |
| Diarrhoea |
6.7% |
| Dizziness |
6.7% |
| Drug Interaction |
6.7% |
| Dyspepsia |
6.7% |
| Headache |
6.7% |
| Hypertension |
6.7% |
| Palpitations |
6.7% |
| Rash Pruritic |
6.7% |
|
